Integra LifeSciences Holdings (IART) Reports In-Line Q3 EPS; Cuts FY11 EPS Outlook
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Join SI Premium – FREE
Integra LifeSciences Holdings (NASDAQ: IART) reported Q3 EPS of $0.77, in-line with the analyst estimate of $0.77. Revenue for the quarter came in at $202.2 million versus the consensus estimate of $204.15 million.
Integra sees FY2011 EPS of $2.88-$2.96, versus prior guidance of $2.92-$3.02 and the consensus of $2.93.
Integra sees FY2011 EPS of $2.88-$2.96, versus prior guidance of $2.92-$3.02 and the consensus of $2.93.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
